Humira (adalimumab) is used to treat several autoimmune conditions. The drug typically stays in your system for a few months after your final dose. This article explains how long Humira may remain in ...

Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose ...

That’s why we need Senate Bill 41, authored by Sen. Scott Wiener, D-San Francisco, which will require a more fair and ...

Drugmaker AbbVie Inc raised its full-year profit forecast on Friday, bolstered by signs of recovery in demand for its Botox injection on easing COVID-19 restrictions and strong growth for its latest ...

If you are looking for dividend stocks that can provide a reliable, long-term income stream, consider buying AbbVie, ...

ALVO accelerates growth with soaring revenues and new biosimilars in ophthalmology, oncology and neurology via global alliances.

AbbVie (ABBV) stands out after its Allergan acquisition thanks to a transformed portfolio and higher long-term growth ...

As U.S. pharma braces for a $236B patent cliff, Chinese biotech surges—and EquitiesFirst unlocks capital with equity-backed ...

AbbVie Inc. is a leading global pharmaceutical company with significant scale and a diversified product portfolio. AbbVie was Carolina Wealth's seventh-largest holding at the end of June. Now it's ...

SCHD offers a rising 3.76% yield, strong dividend growth, and value exposure, making it ideal for income-focused portfolios.

Weight management drugs like the GLP-1 can significantly improve health outcomes, but their exorbitant prices often limit access for many. CVS expects its decision could save an estimated 10-15% year ...

New Zealand's pharma growth complements ongoing FTA negotiations with India to boost pharma trade: Shardul Nautiyal, Mumbai Friday, October 10, 2025, 08:00 Hrs [IST] New Zealand's ...